Table 1 Demographics, Medical History, Biochemistry and CMR values for the CFVR population and the part also examined by PET (MBFR population)
|  | CFVR population, n = 64 | MBFR population, n = 54 |
|---|---|---|
 Age, mean (SD) | 62.5 (8.3) | 62.0 (7.5) |
 Hypertension, n (%) | 38 (59.4) | 29 (53.7) |
 Hyperlipidaemia, n (%) | 42 (65.6) | 34 (63) |
 Family history of CAD, n (%) | 36 (57.1) | 30 (57) |
 Smoking (current), n (%) | 15 (23) | 12 (22) |
 Smoking (previous + current), n (%) | 39 (61) | 34 (63) |
 Pack years (20 cig./day) · year)a, median (IQR) | 27 (7;35) | 29 (8;35) |
 Stable angina pectoris, n (%) | 45 (70.3) | 39 (72) |
 Postmenopausal status, n (%) | 56 (89) | 48 (89) |
 Comorbidity, n (%) | 38 (60) | 31 (59) |
 ESC’s HeartScore (% risk)b, mean (SD) | 1.4 (1.2) | 1.3 (1.3) |
 Framingham risk scorec, mean (SD) | 0.093 (0.05) | 0.094 (0.06) |
Biochemistry | ||
 Total-cholesterol (mmol/l), mean (SD) | 4.8 (1.0) | 4.9 (1.1) |
 LDL cholesterol (mmol/l), mean (SD) | 2.7 (1.0) | 2.8 (1.0) |
 HDL cholesterol (mmol/l), mean (SD) | 1.6 (0.5) | 1.6 (0.5) |
 Non-HDL cholesterol (mmol/l), mean (SD) | 3.2 (1.0) | 3.3 (1.0) |
 Hematocrit, mean (SD) | 40.5 (2.9) | 40.7 (2.7) |
Clinical Assessment | ||
 Body mass index (kg/m2), median (IQR) | 23.9 (21.9;28.3) | 23.7 (22.0;27.9) |
 Body mass index (kg/m2) > 25, n (%) | 26 (41) | 22 (40) |
 Abdominal circumference (cm), mean (SD) | 93.5 (12.4) | 93 (12.5) |
 Systolic blood pressure (mmHg), mean (SD) | 148.1 (25.7) | 146.5 (25.8) |
 Diastolic blood pressure (mmHg), mean (SD) | 85.5 (15.8) | 85.6 (16.5) |
 Heart rate at rest (bpm), mean (SD) | 64.8 (10.3) | 64.2 (11.1) |
 Atherosclerosis at CAG, n (%) | 29 (45) | 24 (44) |
Cardiac Magnetic Resonance (global values) | ||
 Left ventricular ejection fraction (%), mean (SD) | 59.6 (5.9) | 59.7 (5.9) |
 End systolic volume (ml), mean (SD) | 60.6 (17.2) | 61.1 (17.4) |
 End diastolic volume (ml), mean (SD) | 148.5 (27.0) | 150.3 (27.8) |
 Left ventricular mass index (g/m2), mean (SD) | 48.38 (7.6) | 49.1 /7.8) |
 Left ventricular hypertrophy, n (%) | 5 (8) | 5 (10) |
 Cardiac output, mean (SD) | 5.7 (1.1) | 5.7 (1.2) |
 Stroke volume, mean (SD) | 87.9 (15.3) | 89.3 (16.1) |
 Myocardial mass (diastole), mean (SD) | 87.2 (17.8) | 88.2 (18.8) |
 Myocardial mass (systole), mean (SD) | 92.6 (20.7) | 92.9 (21.5) |
Medication | ||
 Beta Blockers, n (%) | 23 (36) | 19 (35) |
 Acetylsalicylic acid, n (%) | 35 (54.7) | 29 (54) |
 Statin, n (%) | 35 (54.7) | 28 (52) |
 Calcium antagonists, n (%) | 17 (27) | 13 (25) |
 Angiotensin conv. enzyme inhibitor, n (%) | 8 (13) | 7 (13) |
 Angiotensin receptor blockers, n (%) | 11 (18) | 6 (11) |